Breast Carcinoma Amplified Sequence 3 (BCAS3) (N-Term) Peptide
BCAS3
Reactivité: Humain
BP
Sodium azide
N° du produit ABIN1382997
-
-
Antigène
Tous les produits BCAS3
-
BCAS3
(Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
Protein Region
-
N-Term
-
Origine
-
Humain
-
Application
-
Blocking Peptide (BP)
-
Attributs du produit
-
18 amino acids near the amino terminus of human BCAS3.
Human
-
-
Indications d'application
-
BCAS3 pepide is used for blocking the activity of BCAS3.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Date de péremption
-
12 months
-
-
Antigène
-
BCAS3
(Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
Synonymes
-
GAOB1 Peptide, MAAB Peptide, 1500019F07Rik Peptide, 2610028P08Rik Peptide, AU021018 Peptide, BC028339 Peptide, K20D4 Peptide, rudhira Peptide, RGD1560788 Peptide, zgc:63764 Peptide, BCAS3 Peptide, BCAS3, microtubule associated cell migration factor Peptide, breast carcinoma amplified sequence 3 Peptide, breast carcinoma-amplified sequence 3 Peptide, BCAS3 Peptide, Bcas3 Peptide, bcas3 Peptide, CpipJ_CPIJ009696 Peptide, LOC100540920 Peptide
-